Filling the Gaps in the Screening Marketplace
Our team of experts and doctors saw the need in the marketplace for noninvasive, contactless screening, and with our Safe Entry Stations, we have done just that. Our new AI products in development will give medical professionals tools that empower their decision-making for better patient outcomes.
Recent Developments
Recent Press
Predictmedix AI Executives Departing This Weekend for Strategic Collaborations in India
Toronto, Ontario – September 20, 2023– Predictmedix AI Inc. (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”) today announced that visas have been granted for a strategic visit to India. The primary purpose of the company’s executives’ visit is to engage with institutional partners and government officials in India, with a keen focus on […]
Predictmedix AI Showcased in Toronto Star Newspaper; Accelerates Oxygen Saturation Parameter to Accommodate Widespread Respiratory Health Issues
Toronto, Ontario – September 12, 2023– Predictmedix AI Inc. (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”) is proud to announce its recent feature in the prestigious Toronto Star newspaper, accompanied by a compelling interview with the company’s COO, Dr. Rahul Kushwah. This exciting development marks a significant milestone in Predictmedix’s journey, enhancing the […]
Predictmedix AI's 2023 Breakthroughs: Pioneering Healthcare Innovation and Global Expansion
Predictmedix AI’s 2023 Breakthroughs: Pioneering Healthcare Innovation and Global Expansion Toronto, Ontario – September 6, 2023– Predictmedix AI Inc. (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”) today provided an update on its achievements and developments so far in 2023. Predictmedix AI, a leader in AI-driven healthcare solutions, has achieved remarkable milestones and […]